INDOCO · Indoco Remedies Limited · Financials
Volume · Nov 13
2889
Avg daily vol (14 sessions)
11.45K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
18.45B
+10.8%
FY2026
Net Income
-951.5M
-29%
FY2026
Operating Cash Flow
1.92B
+102.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| INR | 19.09B | 18.45B | 16.65B | 18.17B | 16.69B | 15.41B | 12.42B | 11.07B |
| INR | 1.33B | 1.26B | 1.14B | 918.7M | 706.1M | 789.6M | 731.3M | 708.2M |
| INR | 1.27B | 1.22B | 662.3M | 380.2M | 250.3M | 141.4M | 222.6M | 262.5M |
| INR | 456M | -1.07B | -743.7M | 1.36B | 1.93B | 2.37B | 1.32B | 285.8M |
| INR | 138.2M | -78.1M | 35.8M | 387.9M | 505.5M | 817.7M | 389.5M | 44.6M |
| INR | 319.4M | -951.5M | -737.4M | 984.7M | 1.42B | 1.55B | 0 | 241.2M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 710.3M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.